GSK Receives US FDA Fast Track Designation for Investigational Vaccine Against Gonorrhoea
Fast Track designation accelerates the vaccine candidate’s path to US FDA submission for the prevention of Neisseria gonorrhoeae infection
Gonorrhoea is the second most prevalent bacterial sexually transmitted infection worldwide with an...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials